Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland

Br J Biomed Sci. 2005;62(1):30-2. doi: 10.1080/09674845.2005.11978067.

Authors

A J McKnight¹, A Shaw, C E Goldsmith, L Clarke, B C Millar, J McCaughan, J S Elborn, A Reid, J E Moore

Affiliation

¹ Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Northern Ireland.

PMID: 15816210
DOI: 10.1080/09674845.2005.11978067

No abstract available

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents / therapeutic use*
Child
Ciprofloxacin / therapeutic use*
Cystic Fibrosis / complications*
Cystic Fibrosis / microbiology
Female
Gram-Negative Bacterial Infections / drug therapy*
Humans
Levofloxacin*
Male
Microbial Sensitivity Tests / methods
Ofloxacin / therapeutic use*
Pseudomonas Infections / drug therapy
Pseudomonas aeruginosa / drug effects
Stenotrophomonas maltophilia / drug effects

Substances

Anti-Bacterial Agents
Anti-Infective Agents
Ciprofloxacin
Levofloxacin
Ofloxacin